Eben@CANSLIM ResearchQuick Take
Analog Devices delivered a 3.3% EPS beat on robust 37% revenue growth, though the shares remain below the 50-day moving average in a Stage 2 advance.
Earnings & Quantitative Scorecard
| Key Metric | Reported / Current | Benchmark / Consensus | Status |
|---|---|---|---|
| Quarterly EPS (C) | $3.45 (+68% YoY) | $3.34 (Surprise: +3.3%) | Pass |
| Quarterly Revenue | $3.62B (+37.2% YoY) | Top-line Growth | Pass |
| Annual EPS Growth (A) | +-5%/yr | ≥25% Annual CAGR | Fail |
| 52-Week High Range (N) | -15.5% off high | Within 15% of High | Lagging |
| Relative Strength (L) | +33.5% vs SPY | Positive Alpha | Pass |
| Institutional Float (I) | 94% | 30% – 90% Float Ownership | Neutral |
| Minervini Trend Template | 6 / 7 Criteria | Stage 2 Uptrend Alignment | Stage 2 (Advancing) |
| Composite CANSLIM Rating | 3 / 7 Pillars | Institutional Quality Setup | 🔴 Lagging / Deteriorating |
Institutional Analysis & Market Backdrop
Analog Devices reported earnings per share of $3.45 for the period, comfortably ahead of the $3.34 consensus, representing a positive surprise of 3.3%. Revenue advanced 37.2% year on year, driven by broad-based demand across industrial, automotive and communications end markets. The company also guided to continued momentum, citing robust order visibility and improving inventory conditions, which helped offset concerns about the pace of the cyclical recovery.
From a technical perspective, the shares trade at $376.59, comfortably above the 200-day moving average of $341.09, confirming the long-term uptrend. However, the price is now below the 50-day moving average of $389.13, suggesting near-term consolidation within the broader Stage 2 advance. With the stock 15.5% below its high, the current action is consistent with a buy-the-dip opportunity only if the 50-day is reclaimed on above-average volume. The CANSLIM score of 3/7 reflects weaker institutional sponsorship and relative strength metrics, favouring a patient approach.
Institutional investors will focus on the durability of the 37% revenue surge, with management signalling that design-win momentum and content per platform remain supportive. Catalysts include continued margin expansion and a recovery in the industrial cycle, while downside risks include inventory normalisation, pricing pressure in analogue components, and a rising rate environment that could compress multiple expansion. Until the stock reclaims its 50-day moving average, conviction remains moderate despite the headline earnings beat.
Stage, pattern and sentiment labels are generated by rule-based approximations (Weinstein stage analysis, Minervini trend template and heuristic pattern detection), not by precise technical analysis. Data as of August 20, 2026. For informational and educational purposes only — not investment advice. Always verify against primary sources before making any investment decision.
Discover more from CANSLIM Research
Subscribe to get the latest posts sent to your email.
